Using vascularized organoids-on-chip for assessing systemic drug delivery

Area of Science:

• Biomedical Engineering
• Organoid Technology
• Disease Modeling

Background:

• Organoids-on-chip offer advanced platforms for drug assessment and disease modeling.
• Vascularization is crucial for mimicking systemic drug delivery and complex biological processes.
• Pancreatic islet spheroids are key models for studying diabetes and autoimmune conditions.

Purpose of the Study:

• To provide a detailed experimental protocol for vascularizing organoids-on-chip.
• To establish a model for autoimmune diseases using pancreatic islet spheroids.
• To facilitate research in inflammation, immunotherapies, and drug development.

Main Methods:

• Development of a hydrogel preparation technique for supporting pancreatic islet spheroids.
• Implementation of a protocol to induce vascularization within the organoid-on-chip system.
• Optimization of the organoids-on-chip model for disease simulation.

Main Results:

• Successful vascularization of pancreatic islet spheroids within the organoids-on-chip platform.
• Demonstration of the model's utility in simulating aspects of autoimmune diseases and inflammation.
• Establishment of a reproducible protocol for researchers.

Conclusions:

• The developed protocol enables the creation of vascularized organoids-on-chip for pancreatic islet studies.
• This model serves as a valuable tool for investigating autoimmune diseases, inflammation, and immunotherapies.
• The platform supports drug screening, toxicity testing, and pharmacokinetic/pharmacodynamic studies.